CureVac

$50.03
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.96 (+1.96%) Today
$0.00 (0.00%) As of 8:00 PM EDT after-hours

Why Robinhood?

You can buy or sell CureVac and other stocks, options, and ETFs commission-free!

About CVAC

CureVac N.V. Ordinary Shares, also called CureVac, is a clinical-stage biopharmaceutical Company developing tumour immunotherapy. Read More It offers RNA optimization that encode functional proteins that replace defective or missing proteins using the cell's intrinsic translation machinery. The company was founded by Ingmar Hoerr and Florian von der Mülbe in 2000 and is headquartered in Tübingen, Germany. The listed name for CVAC is CureVac N.V. Ordinary Shares.

Employees
454
Headquarters
Tubingen, Baden Wuerttemberg
Founded
2000
Market Cap
8.90B
Price-Earnings Ratio
Dividend Yield
Average Volume
333.67K
High Today
$52.89
Low Today
$49.56
Open Price
$51.88
Volume
688.07K
52 Week High
$85.00
52 Week Low
$36.15

Collections

You May Also Like